[Autoimmune hepatitis in children and adolescents: clinical study, diagnosis and therapeutic response]

Alexandre R Ferreira1, Mariza L V Roquete, Francisco J Penna

  • 1Gastroenterologia Pediátrica, Universidade Federal de Minas Gerais, Belo Horizonte, MG. alexfer@net.em.com.br

Jornal De Pediatria
|December 4, 2003
PubMed

Insights

This study on autoimmune hepatitis (AIH) in pediatric patients found that immunosuppression treatment was effective, though corticosteroids may impact height. Key findings include female predominance and specific histopathological markers.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Immunology

Context:

  • Autoimmune hepatitis (AIH) is a chronic liver disease of unknown etiology.
  • AIH in children and adolescents presents unique clinical, laboratory, and histopathological characteristics.
  • Understanding these features is crucial for effective management and treatment strategies.

Purpose:

  • To evaluate the clinical, laboratory, and histopathological features of AIH in pediatric patients.
  • To assess the response to immunosuppressive therapy in this cohort.
  • To identify potential adverse effects of treatment, such as impact on growth.

Summary:

  • The study analyzed 39 children and adolescents with AIH, noting a female predominance (87.2%) and diverse clinical presentations (chronic, acute, hepatic failure).
  • Key laboratory findings included elevated aminotransferases and gamma-globulin. Histopathology revealed significant piecemeal necrosis, portal inflammation, and cirrhosis.
  • Immunosuppressive treatment, primarily corticosteroids and azathioprine, achieved complete resolution in 77.8% of patients, but 17.9% died. A significant reduction in height/age z-score was observed, likely due to corticosteroid side effects.

Impact:

  • This research provides valuable insights into the multifaceted nature of AIH in pediatric populations.
  • It highlights the efficacy of current immunosuppressive treatments while underscoring the need to monitor for adverse effects like growth impairment.
  • Findings can inform clinical practice guidelines for managing pediatric AIH, optimizing treatment protocols, and improving patient outcomes.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...